Cancers are the second most common cause of death worldwide. In 2020, there were over 19 million new cancer cases and more than 10 million cancer deaths. From advancing our understanding of the disease to improving care for cancer patients, cancer biomarkers are playing an important role.
For this special issue, we will consider original research papers, technical notes, clinical trials, perspectives, key paper evaluations and full and mini-reviews that focus on the current techniques, protocols, reagents, databases, statistical approaches and/or software programs. We are interested in papers that explore how these elements are contributing to the discovery and validation of cancer biomarkers for prevention, diagnosis (including sub-categorisation of the disease), prognosis or therapeutic responses. We also welcome reviews on both a single target analysis or high-throughput omics analysis.
Important Dates and Deadlines:
- Submission of papers: rolling submission
- Dr. Norman H. L. Chiu, University of North Carolina Greensboro, USA. Email: firstname.lastname@example.org
- Dr. William Cho, Queen Elizabeth Hospital, Hong Kong, China. Email: email@example.com
- Dr. Wen-Jun Tu, Chinese Academy of Medical Sciences - Peking Union Medical College, Tianjin, China. Email: firstname.lastname@example.org